If you need more lookups,
subscriptions start at $34 USD/month.
Ali Khateb Location
San Francisco, CA, US
Ali Khateb Work
2026 -now Senior Principal Scientist, Oncology Discovery @
2024 -2026 Principal Scientist, Oncology Discovery @
2021 -2024 Scientist II, Immuno-Oncology @
2019 -2021 Postdoctoral Researcher (NCI-designated Cancer Center) @
Ali Khateb Education
Technion - Israel Institute of Technology (Technion Integrated Cancer Center)
Doctor of Philosophy - PhD (Direct PhD Program) (Medical Science)
2016-2019
Technion - Israel Institute of Technology
Master's degree (Medical Science)
2014-2016
Technion - Israel Institute of Technology
Bachelor's degree (Biology, General)
2011-2014
Ali Khateb Skills
Molecular Biology
Oncology
Cell Biology
Biochemistry
High Throughput Screening
Crispr
FACS
Proteomics
Protein Chemistry
Cell Signaling
Immunohistochemistry
Immunofluorescence
Immunology
Immunocytochemistry
Chromatin Immunoprecipitation
Western Blotting
Real-Time Polymerase Chain Reaction (qPCR)
Polymerase Chain Reaction (PCR)
Epigenetics
Tissue Culture
Immunoprecipitation
Genomics
Molecular Cloning
Cell Fractionation
Bacterial Transformation
Protein Purification
Transfection
Grant Writing
ELISA
Primary Cell Isolation
Drug Testing
Compound Screening
Flow Cytometry
Tumor Immunology
cytof
in vivo
Microsoft Word
Microsoft Office
Ali Khateb Summary
Ali Khateb, based in San Francisco, CA, US, is currently a Senior Principal Scientist, Oncology Discovery at Kimia Therapeutics. Ali Khateb brings experience from previous roles at Kimia Therapeutics, NGM Biopharmaceuticals and Sanford Burnham Prebys Medical Discovery Institute. Ali Khateb holds a 2016 - 2019 Doctor of Philosophy - PhD (Direct PhD Program) in Medical Science @ Technion - Israel Institute of Technology (Technion Integrated Cancer Center). With a robust skill set that includes Molecular Biology, Oncology, Cell Biology, Biochemistry, High Throughput Screening and more. Ali Khateb has 2 emails on RocketReach.
Looking for a different Ali Khateb?
Find contact details for 700 million professionals.